U.S.-Korea Free Trade Agreement: Potential Economy-wide ... - USITC
U.S.-Korea Free Trade Agreement: Potential Economy-wide ... - USITC
U.S.-Korea Free Trade Agreement: Potential Economy-wide ... - USITC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
use of TBTs to protect <strong>Korea</strong>’s auto market from imports. 49 As such, this would be the first<br />
time a TBT chapter of an FTA negotiated by the United States would contain provisions that<br />
address TBTs with respect to a specific industry. 50 Other U.S. product sectors that would<br />
potentially benefit from the provisions include pharmaceuticals, medical devices,<br />
biotechnology, cosmetics, transportation equipment, telecommunications and other IT<br />
equipment, electrical equipment and household appliances, construction materials and<br />
equipment, food and beverage products, and energy services and equipment. 51<br />
U.S. industry and government officials indicate that in their view <strong>Korea</strong>’s application of its<br />
certification, testing, regulatory, labeling, and other standards-related practices often do not<br />
conform with WTO guidelines and, thus, serve as TBTs. 52 The United States and other<br />
<strong>Korea</strong>n trading partners contend that “lack of transparency and insufficient coordination<br />
[have] generated a rather complex standardization and certification system,” with <strong>Korea</strong>n<br />
regulatory agencies’ rules too often overlapping one another. 53 The <strong>Korea</strong>n government<br />
reportedly sometimes issues new regulations without adequate public consultation and<br />
comment opportunities. 54 The FTA addresses these issues by increasing both transparency<br />
and opportunities for U.S. industry participation in the <strong>Korea</strong>n standards process. 55 This<br />
should reduce the likelihood of duplicative or discriminatory technical regulations being<br />
developed in <strong>Korea</strong> that could serve as technical barriers to U.S. exports.<br />
U.S. industry officials contend that <strong>Korea</strong>’s technical regulations and conformity assessment<br />
procedures currently apply differently to imports than to domestic products. 56 They state that<br />
<strong>Korea</strong>n regulatory authorities often require that imported products such as medical devices,<br />
pharmaceuticals, chemicals (and chemical products), and electronics, and information<br />
technology equipment have prior regulatory approval in their home countries before they<br />
may be submitted for approval consideration in <strong>Korea</strong>. 57 Further, <strong>Korea</strong> reportedly<br />
sometimes requires use of “standards unique to <strong>Korea</strong> even when international standards<br />
49 Stangarone, “Anatomy of a Deal: The U.S.-<strong>Korea</strong>n FTA,” April 2007, 1.<br />
50 Although not as extensive as the automotive provisions, the proposed FTA also includes a provision<br />
requiring each party to take steps to implement Phase II of the APEC Mutual Recognition Arrangement for<br />
Conformity Assessment of Telecommunications Equipment with respect to the other party as soon as<br />
possible for the purpose of reducing technical and regulatory barriers to trade in this sector. USTR, “Final -<br />
United States - <strong>Korea</strong> FTA Texts,” 2007, Article 9.5.5.<br />
51 USCIA, “<strong>Korea</strong>, South,” June 19, 2007, 1; EIU, “Country Commerce: South <strong>Korea</strong>,” July 2006, 106;<br />
USTR, “<strong>Korea</strong>,” 2006 National <strong>Trade</strong> Estimate Report on Foreign <strong>Trade</strong> Barriers, March 31, 2006,<br />
358–361; and U.S. industry officials, telephone interviews by Commission staff, May 7–9, 2007. For<br />
additional information on tariff and nontariff measures in <strong>Korea</strong> potentially affecting the U.S. automotive<br />
industry, see the sector-specific analysis on motor vehicles in chap. 3.<br />
52 Kiyota and Stern, “Economic Effects of a <strong>Korea</strong>-U.S. <strong>Free</strong> <strong>Trade</strong> <strong>Agreement</strong>,” 2007, 8; USFCS, “<strong>Korea</strong><br />
<strong>Trade</strong> Regulations and Standards,” 2005, 76–81; and U.S. industry officials, telephone interviews by<br />
Commission staff, May 7–9, 2007.<br />
53 WTO, <strong>Trade</strong> Policy Review Body (TPRB), “TPR, Republic of <strong>Korea</strong>, Report by the Secretariat,”<br />
September 17, 2004, 58.<br />
54 USFCS, “<strong>Korea</strong> <strong>Trade</strong> Regulations and Standards,” 2005, 76–81.<br />
55 Dawson, testimony before the <strong>USITC</strong>, June 20, 2007, 71.<br />
56 Primosch, testimony before the <strong>Trade</strong> Policy Staff Committee, Office of the USTR, March 14, 2006, 5;<br />
Dawson, testimony before the <strong>USITC</strong>, June 20, 2007, 127; and U.S. industry officials, telephone interviews<br />
by Commission staff, May 7–9, 2007.<br />
57 EIU, “Country Commerce: South <strong>Korea</strong>,” July 2006, 106; USTR, “<strong>Korea</strong>,” 2007 National <strong>Trade</strong><br />
Estimate Report on Foreign <strong>Trade</strong> Barriers, April 2, 2007, 358–361; Gross and Minot, “Medical Device<br />
Registration in <strong>Korea</strong>: An Overview,” January 2007, 1–4; and U.S. industry officials, telephone interviews<br />
by Commission staff, May 7–9, 2007.<br />
5-9